Furthermore, we provide in vivo evidence that the subcutaneous injection of apoptotic lung cancer cells decreases the number of visible lung metastases of the primary subcutaneous tumor via PPARγ/PTEN signaling. This evidence concerns the gene PPARG and lung carcinoma.